Rating History for Innate Pharma S.A. (ipha) by Leerink

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/11/2026 Daina Graybosch Upgrade Outperform
(Market Perform)
4.00
(N/A)
2.22
(2.15)
-3.15% Details